All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | TCR Clone | Host Species | Epitope | Allele | Vector Type | Inquiry & Datasheet |
TCR-YC0281 | Human anti-C76H142O15 T cell receptor (Clone 20), pCDTCR1 | Mycobacterium tuberculosis | clone 20 | Human | alpha,alpha'-trehalose 6,6'-bismycolate | human CD1b | Lentiviral vector | |
TCR-YC0282 | Human anti-C76H142O15 T cell receptor (Clone 28 C58L), pCDTCR1 | Mycobacterium tuberculosis | clone 28 C58L | Human | alpha,alpha'-trehalose 6,6'-bismycolate | human CD1b | Lentiviral vector | |
TCR-YC0283 | Human anti-C76H142O15 T cell receptor (DN1), pCDTCR1 | Mycobacterium tuberculosis | DN1 | Human | alpha,alpha'-trehalose 6,6'-bismycolate | human CD1b | Lentiviral vector | |
TCR-YC0284 | Human anti-C76H142O15 T cell receptor (GEM18), pCDTCR1 | Mycobacterium tuberculosis | GEM18 | Human | alpha,alpha'-trehalose 6,6'-bismycolate | human CD1b | Lentiviral vector |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION